Category: Gastro-Hep News
Gastro-Hep News
Guidelines Released for the Diagnosis and Treatment of Achalasia The American College of Gastroenterology released guidelines on the diagnosis and treatment of achalasia, including recommendations, key […]
Gastro-Hep News
Risk of Small-Bowel Cancers Higher Among Patients With Celiac Disease Patients with celiac disease have a significantly increased risk of small-bowel adenocarcinomas and adenomas, but not […]
Gastro-Hep News
COVID-19 Assistance Program Provides Crohn’s Disease Patients With Access to Serum-Based Test An assistance program (Monitr COVID-19 Assistance Program, Prometheus Biosciences) has been launched to provide […]
Gastro-Hep News
Esophageal DNA Test Granted US Food and Drug Administration Breakthrough Device Status The US Food and Drug Administration (FDA) has granted Breakthrough Device status to […]
Gastro-Hep News
US Food and Drug Administration Approves Use of Duodenoscope With Disposable Elevator Component The US Food and Drug Administration (FDA) approved the use of a duodenoscope […]
Gastro-Hep News
US Food and Drug Administration Approves Use of Colorectal Cancer Screening Test in Younger Adults On September 23, 2019, the US Food and Drug Administration (FDA) […]
Gastro-Hep News
First-Degree Relatives of Individuals With Celiac Disease at Higher Risk of Diagnosis First-degree relatives (FDRs) of individuals diagnosed with celiac disease (CD) have an increased risk […]
Gastro-Hep News
US Preventive Services Task Force Reaffirms Hepatitis B Virus Screening in Pregnant Women All pregnant women should still b8e screened for hepatitis B virus (HBV) infection […]
Gastro-Hep News
US Food and Drug Administration Approves Marketing of Medical Device for Reduction of IBS-Associated Pain in Adolescents On June 7, 2019, the US Food and Drug […]
Gastro-Hep News
US Food and Drug Administration Approves Teduglutide for Pediatric Patients With Short Bowel Syndrome On May 17, 2019, the US Food and Drug Administration (FDA) expanded […]
Gastro-Hep News
Liquid Biopsies Show Potential in Detecting Early-Stage Hepatocellular Carcinoma in Patients With Hepatitis B Virus Infection Liquid biopsies, based on a combination of cell-free DNA (cfDNA) […]
Gastro-Hep News
Diet Low in Sugar Improves Nonalcoholic Fatty Liver Disease in Adolescent Patients Compared to a standard diet, a diet low in free sugars led to a […]
Gastro-Hep News
Same-Day Bowel Preparation Ideal for Afternoon Colonoscopies Same-day bowel preparation provides better cleansing and is preferred over a split-dose regimen for patients scheduled for an afternoon […]
Gastro-Hep News
European Commission Approves Fifth Adalimumab Biosimilar On September 20, 2018, the European Commission (EC) granted marketing authorization for the adalimumab (Humira, AbbVie) biosimilar Hulio (Mylan and […]
Gastro-Hep News
US Food and Drug Administration Approves Lenvatinib for Hepatocellular Carcinoma On August 16, 2018, the US Food and Drug Administration (FDA) approved the kinase inhibitor lenvatinib […]
Gastro-Hep News
Detectable Fecal Hemoglobin Associated With Higher Rates of All-Cause Mortality Patients with detectable fecal hemoglobin have an increased risk of death from a variety of causes, […]
Gastro-Hep News
Pancreatic Cancer Associated With Recent-Onset Diabetes Recent-onset diabetes is associated with a significantly higher risk of pancreatic cancer among African American and Latino individuals, according to […]
Gastro-Hep News
Inflammatory Bowel Disease Associated With Increased Risk of Myocardial Infarction Patients with inflammatory bowel disease (IBD), particularly women and patients between ages 20 to 25 years, […]
Gastro-Hep News
US Food and Drug Administration Approves Infliximab Biosimilar On December 14, 2017, the US Food and Drug Administration (FDA) approved the infliximab (Remicade, Janssen) biosimilar infliximab-qbtx […]
Gastro-Hep News
US Food and Drug Administration Clears Duodenoscope With Disposable Distal Cap On September 20, 2017, the US Food and Drug Administration (FDA) cleared the first duodenoscope […]